• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动合并阻塞性睡眠呼吸暂停综合征患者心房颤动复发风险的预测模型及评分系统:一项回顾性病例对照研究

Prediction model and scoring system for the risk of atrial fibrillation recurrence in patients with atrial fibrillation and obstructive sleep apnoea syndrome: a retrospective case-control study.

作者信息

Zhang Xiaoting, Wei Meng, Xue Pengjie, Lu Yanmei, Tang Baopeng

机构信息

Department of Cardiac Pacing and Electrophysiology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830000, China.

Xinjiang Key Laboratory of Cardiac Electrophysiology and Cardiac Remodeling, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830000, China.

出版信息

BMC Cardiovasc Disord. 2025 Apr 23;25(1):308. doi: 10.1186/s12872-025-04696-7.

DOI:10.1186/s12872-025-04696-7
PMID:40269690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12016155/
Abstract

BACKGROUND

The high prevalence of atrial fibrillation (AF) and obstructive sleep apnea syndrome (OSAS) imposes a substantial disease burden on public healthcare, making it a significant health concern in the current era. However, there is currently a lack of risk assessment tools for AF recurrence in patients with AF and OSAS. Therefore, this study aims to explore the factors influencing AF recurrence in patients with AF and OSAS, and to establish a predictive model and scoring system for AF recurrence rates.

METHODS

The study included a total of 423 patients with AF and OSAS, who were randomly divided into train set (n = 296) and test set (n = 127) in a ratio of 7:3. Afterwards, the train set was split into a recurrence group and a non-recurrence group for further analysis of indicators while in hospital.

RESULTS

Following Lasso regression screening, 8 variables were selected from a pool of 62 variables from patients with AF and OSAS. Additionally, the study incorporated the CHADS-VASc score and its components of interest, the severity of OSAS and hypoxemia, and whether patients received catheter ablation (CA). Multivariable Cox regression analysis revealed: Hb < 115 g/L (HR = 2.27), P > 1.51mmol/L (HR = 3.77), PCT > 2ng/ml (HR = 15.72) as independent risk factors. Hb > 150 g/L (HR = 0.66), TT4 < 66 nmol/L (HR = 0.16) were identified as independent protective factors. The train set showed AUC values of 0.65, 0.71, and 0.71 at the 1st, 3rd, and 5th year, respectively, while the validation set displayed AUC values of 0.60, 0.59, and 0.64 at the 1st, 3rd, and 5th year, respectively, indicating good predictive performance of the model. The AF recurrence rate scoring system categorized patients in the train and test sets into low-risk, medium-risk, and high-risk groups, with HR values of 2.36 and 6.79 for AF recurrence rates in the medium-risk and high-risk groups of the train set, and an HR value of 2.77 for the medium-risk group in the test set.

CONCLUSION

The predictive models and scoring systems developed in this study demonstrate good predictive ability in assessing the recurrence of AF in patients with OSAS, offering invaluable clinical guidance and references.

CLINICAL TRIAL NUMBER

Not applicable.

摘要

背景

心房颤动(AF)和阻塞性睡眠呼吸暂停综合征(OSAS)的高患病率给公共医疗保健带来了沉重的疾病负担,使其成为当前时代的一个重大健康问题。然而,目前缺乏针对AF合并OSAS患者AF复发的风险评估工具。因此,本研究旨在探讨影响AF合并OSAS患者AF复发的因素,并建立AF复发率的预测模型和评分系统。

方法

本研究共纳入423例AF合并OSAS患者,按照7:3的比例随机分为训练集(n = 296)和测试集(n = 127)。之后,将训练集分为复发组和未复发组,以便在住院期间进一步分析指标。

结果

经过Lasso回归筛选,从AF合并OSAS患者的62个变量中选择了8个变量。此外,该研究纳入了CHADS-VASc评分及其相关成分、OSAS和低氧血症的严重程度,以及患者是否接受导管消融(CA)。多变量Cox回归分析显示:血红蛋白<11​​5 g/L(HR = 2.27)、磷>1.51mmol/L(HR = 3.77)、降钙素原>2ng/ml(HR = 15.72)为独立危险因素。血红蛋白>150 g/L(HR = 0.66)、总甲状腺素<66 nmol/L(HR = 0.16)被确定为独立保护因素。训练集在第1年、第3年和第5年的AUC值分别为0.65、0.71和0.71,而验证集在第1年、第3年和第5年的AUC值分别为0.60、0.59和0.64,表明该模型具有良好的预测性能。AF复发率评分系统将训练集和测试集的患者分为低风险、中风险和高风险组,训练集中风险组和高风险组的AF复发率HR值分别为2.36和6.79,测试集中风险组的HR值为2.77。

结论

本研究开发的预测模型和评分系统在评估OSAS患者AF复发方面具有良好的预测能力,提供了宝贵的临床指导和参考。

临床试验编号

不适用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/1a0d6f35a592/12872_2025_4696_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/b33b617bc771/12872_2025_4696_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/da55eb35902f/12872_2025_4696_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/febee4605a8c/12872_2025_4696_Fig3a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/1a0d6f35a592/12872_2025_4696_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/b33b617bc771/12872_2025_4696_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/da55eb35902f/12872_2025_4696_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/febee4605a8c/12872_2025_4696_Fig3a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478b/12016155/1a0d6f35a592/12872_2025_4696_Fig4_HTML.jpg

相似文献

1
Prediction model and scoring system for the risk of atrial fibrillation recurrence in patients with atrial fibrillation and obstructive sleep apnoea syndrome: a retrospective case-control study.心房颤动合并阻塞性睡眠呼吸暂停综合征患者心房颤动复发风险的预测模型及评分系统:一项回顾性病例对照研究
BMC Cardiovasc Disord. 2025 Apr 23;25(1):308. doi: 10.1186/s12872-025-04696-7.
2
CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.CHADS2 和 CHA2DS2-VASc 评分作为预测阵发性心房颤动左心房消融结局的指标。
Europace. 2014 Feb;16(2):202-7. doi: 10.1093/europace/eut210. Epub 2013 Jun 28.
3
Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients.严重阻塞性睡眠呼吸暂停患者中房颤消融的疗效不佳。
Europace. 2010 Aug;12(8):1084-9. doi: 10.1093/europace/euq128. Epub 2010 May 20.
4
Prevalence and predictors of Sleep Apnea in Atrial Fibrillation patients.房颤患者睡眠呼吸暂停的患病率及其预测因素。
Tunis Med. 2020 Dec;98(12):1031-1038.
5
The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.风险评分(CHADS2与CHA2DS2-VASc)对心房颤动消融术后长期预后的影响。
Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.
6
Hypertension and Atrial Fibrillation: What is the prevalence of obstructive sleep apnea syndrome?高血压与心房颤动:阻塞性睡眠呼吸暂停综合征的患病率是多少?
Tunis Med. 2018 Mar;96(3):187-192.
7
Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.阻塞性睡眠呼吸暂停严重程度指标——呼吸暂停低通气指数对肥厚型心肌病合并心房颤动患者的影响。
J Am Heart Assoc. 2020 Apr 21;9(8):e015013. doi: 10.1161/JAHA.119.015013. Epub 2020 Apr 16.
8
The Value of the CHADS and CHADS-VASc Score for Predicting the Prognosis in Lacunar Stroke with or without Atrial Fibrillation Patients.CHA2DS2-VASc 评分对伴有或不伴有心房颤动的腔隙性卒中患者预后预测的价值。
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104143. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.027. Epub 2019 Aug 30.
9
Atrial Fibrillation Is Associated With Increased Mean Platelet Volume and Apnea Hypopnea Index in Patients With Obstructive Sleep Apnea.心房颤动与阻塞性睡眠呼吸暂停患者的平均血小板体积增加及呼吸暂停低通气指数相关。
Angiology. 2015 Jul;66(6):525-30. doi: 10.1177/0003319714548567. Epub 2014 Aug 26.
10
Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.比较 CHADS2、R2CHADS2 和 CHA2DS2-VASc 评分在预测心房颤动导管消融后节律转归中的作用:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):281-7. doi: 10.1161/CIRCEP.113.001182. Epub 2014 Mar 8.

引用本文的文献

1
Prevalence and Diagnosis of Obstructive Sleep Apnea in Atrial Fibrillation Patients: A Systematic Review.心房颤动患者阻塞性睡眠呼吸暂停的患病率与诊断:一项系统评价
J Clin Med. 2025 Aug 12;14(16):5708. doi: 10.3390/jcm14165708.

本文引用的文献

1
Association between blood phosphorus level and adverse outcomes in patients with coronary artery disease: A meta-analysis.血磷水平与冠心病患者不良结局之间的关联:一项荟萃分析。
Heliyon. 2024 Sep 26;10(19):e38565. doi: 10.1016/j.heliyon.2024.e38565. eCollection 2024 Oct 15.
2
Effects of Longitudinal Changes in Anemia Status on Clinical Outcomes in Patients With Non-Valvular Atrial Fibrillation - Analysis From the Hokuriku-Plus AF Registry.
Circ J. 2025 Jan 24;89(2):164-173. doi: 10.1253/circj.CJ-24-0132. Epub 2024 Aug 27.
3
Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.预测 2050 年之前美国心血管疾病和中风的经济负担:美国心脏协会主席的咨询报告。
Circulation. 2024 Jul 23;150(4):e89-e101. doi: 10.1161/CIR.0000000000001258. Epub 2024 Jun 4.
4
Genetically predicted systemic inflammation and the risk of atrial fibrillation: A bidirectional two-sample Mendelian randomization study.基因预测的全身炎症与心房颤动风险:一项双向双样本孟德尔随机化研究。
Int J Cardiol Heart Vasc. 2024 May 6;52:101422. doi: 10.1016/j.ijcha.2024.101422. eCollection 2024 Jun.
5
The Burden of Comorbidities in Obstructive Sleep Apnea and the Pathophysiologic Mechanisms and Effects of CPAP.阻塞性睡眠呼吸暂停中共病的负担以及持续气道正压通气的病理生理机制和影响
Clocks Sleep. 2023 Jun 19;5(2):333-349. doi: 10.3390/clockssleep5020025.
6
Mechanism and management of atrial fibrillation in the patients with obstructive sleep apnea.阻塞性睡眠呼吸暂停患者心房颤动的机制与管理
J Arrhythm. 2022 Sep 27;38(6):974-980. doi: 10.1002/joa3.12784. eCollection 2022 Dec.
7
Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea: The SLEEP-AF Study.CPAP 对阻塞性睡眠呼吸暂停患者心房颤动基质的影响:SLEEP-AF 研究。
JACC Clin Electrophysiol. 2022 Jul;8(7):869-877. doi: 10.1016/j.jacep.2022.04.015. Epub 2022 Jun 29.
8
Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study.中国心房颤动的患病率及风险:一项全国性横断面流行病学研究。
Lancet Reg Health West Pac. 2022 Apr 11;23:100439. doi: 10.1016/j.lanwpc.2022.100439. eCollection 2022 Jun.
9
Impact of undiagnosed obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation (OSA-AF study).未诊断的阻塞性睡眠呼吸暂停对导管消融术后房颤复发的影响(OSA-AF研究)
Int J Cardiol Heart Vasc. 2022 Mar 24;40:101014. doi: 10.1016/j.ijcha.2022.101014. eCollection 2022 Jun.
10
The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis.阻塞性睡眠呼吸暂停(OSA)的无形代价:系统评价和疾病成本分析。
PLoS One. 2022 May 20;17(5):e0268677. doi: 10.1371/journal.pone.0268677. eCollection 2022.